Nitric oxide inhibits APO-1/Fas-mediated cell death

Cell Growth Differ. 1998 May;9(5):415-22.

Abstract

Activation of the cysteine protease caspases, which are homologous to the product of Caenorhabditis elegans cell-death gene ced 3, is required to mediate APO-1/Fas-induced apoptosis. We report here that nitric oxide (NO) released by exogenous NO donors, as well as NO endogenously derived by transfection with the inducible NO synthase, substantially suppresses APO-1/Fas-triggered cell death of Jurkat cells. The inhibitory NO effect was independent of cGMP, because 8-bromo-cGMP did not influence APO-1/Fas-mediated apoptosis. In contrast, NO interferes with the APO-1/Fas-induced stimulation of caspases. NO inhibits the proteolytic cleavage of caspase-3 (CPP32) into its active subunits, thereby suppressing caspase-3 activity. In addition, NO potently inhibits apoptosis induction by overexpresssion of the death domain protein FADD or the immediate downstream target caspase-8. These results suggest that NO modulates the proteolytic cascade upstream of caspase-3. Indeed, NO specifically S-nitrosylates caspase-8 and caspase-1 and thereby may prevent activation of the proteolytic cascade. The NO-mediated increase in the resistance toward induction of apoptosis may play a major role in mediating immune responses, as well as in the pathogenesis of autoimmune diseases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptor Proteins, Signal Transducing*
  • Animals
  • Antibodies / pharmacology
  • Apoptosis*
  • Carrier Proteins / metabolism
  • Caspase 1
  • Caspase 3
  • Caspase 8
  • Caspase 9
  • Caspases*
  • Cycloheximide / pharmacology
  • Cysteine Endopeptidases / metabolism
  • Dactinomycin / pharmacology
  • Dose-Response Relationship, Drug
  • Fas-Associated Death Domain Protein
  • Glutathione / analogs & derivatives
  • Glutathione / pharmacology
  • Humans
  • Jurkat Cells
  • Mice
  • Nitric Oxide / metabolism
  • Nitric Oxide / pharmacology
  • Nitric Oxide / physiology*
  • Nitric Oxide Synthase / genetics
  • Nitric Oxide Synthase / metabolism
  • Nitric Oxide Synthase Type II
  • Nitroprusside / pharmacology
  • Nitroso Compounds / pharmacology
  • Penicillamine / analogs & derivatives
  • Penicillamine / pharmacology
  • Protein Synthesis Inhibitors / pharmacology
  • S-Nitrosoglutathione
  • Signal Transduction
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / metabolism
  • T-Lymphocytes / pathology*
  • fas Receptor / immunology
  • fas Receptor / physiology*

Substances

  • Adaptor Proteins, Signal Transducing
  • Antibodies
  • Carrier Proteins
  • FADD protein, human
  • Fadd protein, mouse
  • Fas-Associated Death Domain Protein
  • Nitroso Compounds
  • Protein Synthesis Inhibitors
  • S-nitro-N-acetylpenicillamine
  • fas Receptor
  • Nitroprusside
  • Dactinomycin
  • Nitric Oxide
  • S-Nitrosoglutathione
  • Cycloheximide
  • NOS2 protein, human
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type II
  • Nos2 protein, mouse
  • CASP3 protein, human
  • CASP8 protein, human
  • CASP9 protein, human
  • Casp3 protein, mouse
  • Casp8 protein, mouse
  • Casp9 protein, mouse
  • Caspase 3
  • Caspase 8
  • Caspase 9
  • Caspases
  • Cysteine Endopeptidases
  • Caspase 1
  • Glutathione
  • Penicillamine